Total Artificial Heart (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
This Medical Devices sector report, “Total Artificial Heart (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart. One unit refers to one total artificial heart.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The report enables you to -
Summary
This Medical Devices sector report, “Total Artificial Heart (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart. One unit refers to one total artificial heart.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Total Artificial Heart under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Total Artificial Heart under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Total Artificial Heart - Pipeline Products under Development by Companies
5 Total Artificial Heart Companies and Product Overview
6 Total Artificial Heart- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abiomed Inc
- BioLife4D Corp
- BiVacor Pty Ltd
- Carmat SAS
- Cleveland Clinic Lerner College of Medicine
- Cleveland Heart Inc
- Foster-Miller Inc (Inactive)
- Griffith University
- Indian Institute of Technology Kharagpur
- Lausanne University Hospital
- OregonHeart Inc (Inactive)
- ReliantHeart, Inc.
- Scandinavian Real Heart AB
- Suzhou Tongxin Medical Equipment Co Ltd
- Syncardia Systems LLC
- TEDA International Cardiovascular Hospital
- University of Tokyo
- Yale University
